700
Registro EXTINTO, com base na norma legal indicada.
INCISO I DO ART. 142 DA LPI.
RPI 1460
12/29/1998
Back to search
Official data from INPI
PIMAFUCORT
This trademark appears in the official INPI history.
Even when the status is closed, the history helps calibrate risk, avoid repeating mistakes, and define a safe naming strategy.
Registro ExtintoType: WordOffice: Brazil
Progress at the INPI
- Filing04/05/67
- Publication
- Examination
- Allowance
- Grant06/10/77
- Terminated12/29/98
The registration was granted on 06/10/1977 and later terminated. The mark is no longer protected.
Check whether this name is availableLatest action published by the INPI: 12/29/1998. We update with every new RPI gazette, published weekly.
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
INPI status
Registro Extinto
Case type
Application and registration
Recorded events
5
Latest update
12/29/1998
Trademark type
Word
Nice classes
5
Filing date
04/05/1967
Registration date
06/10/1977
Expiration date
06/10/1997
Complete case details
Structured fields from the responsible authority and the official record.
Nature
De Produto
Responsible office
Brazil
Owner type
NÃO RESIDENTE
Owner location
NL
Holders and representatives
Holders
ASTELLAS PHARMA EUROPE B.V.
Representatives
No representative data.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicamentos antibióticos e quimioterápicos
Publications
History of INPI decisions and trademark events.
5 publications found
565
ANOTADA A TRANSFERENCIA.
CED. GIST-BROCADES N.V. (NL) RETIFICAÇÃO DA PUBLICAÇÃO DA TRANSF. ANOTADA NA RPI 1131 DE 04/08/92, TENDO EM VISTA ERRO NO NOME DA TITULAR * INT. DANNEMANN
RPI 1155
01/19/1993
565
ANOTADA A TRANSFERENCIA.
CED. GIST _ BROCADES N.V. (NL) * INT.
RPI 1141
10/13/1992
565
ANOTADA A TRANSFERENCIA.
CED. GIST-BROCADES N.V.(NL) * INT. DANNEMANN
RPI 1131
08/04/1992
990
CONCEDIDA A PRORROGACAO DO REGISTRO. O Certificado de prorrogacao de Registro estara a disposicao do Titular na Recepcao da Diretoria de Marcas, apos 60 (sessenta) dias a contar desta data. Podera, a pedido, ser remetido a qualquer Delegacia e/ou Representacao do INPI/MICT.
INT. DANNEMANN, SIEMSEN, BIGLER & IPANEMA MOREIRA.
RPI 956
02/14/1989
ASTELLAS PHARMA EUROPE B.V. also protects technology and design at the INPI
3 patent applications under the same owner.
Continuous trademark protection
Get notified about every new filing that threatens PIMAFUCORT or your mark.
Professional 24-month watch service: we monitor INPI for you and alert you in time to oppose — before conflicts become losses.